Concepedia

Wei Xu

WX

Statistics

Publications

29

Citations

2.5K

H-Index

22

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Roche (Switzerland)

Sun Yat-sen University

Peking University

Roche Pharma AG (Germany)

Wei Xu is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer immunology.

ORCID

Publications per year

2010–2024

29

Publications

29

Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

Min Hee Oh, Im‐Hong Sun, Liang Zhao et al. · Journal of Clinical Investigation · 2020 · 433 citations · Full text

, , +17

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Maud Mayoux, Andreas Roller, Vesna Pulko et al. · Science Translational Medicine · 2020 · 380 citations

, , +17

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus, Claudia Ferrara, Wei Xu et al. · Science Translational Medicine · 2019 · 266 citations · Full text

, , +17

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity

Sabine Hoves, Chia-Huey Ooi, Hadassah Sade et al. · The Journal of Experimental Medicine · 2018 · 215 citations · Full text

, , +17

Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells

Ann H. Klopp, Lara Lacerda, Anshul Gupta et al. · PLoS ONE · 2010 · 174 citations · Full text

, , +10

1–5 of 29